Skip to main content
. 2021 Apr 14;11:8195. doi: 10.1038/s41598-021-87499-y

Table 3.

Risk of various myopia among different types of DM and the control cohort.

Control
(n = 71,076)
Type 1 DM
(n = 2,174)
Type 2 DM
(n = 33,364)
Adjusted HR
(95% CI)
Adjusted HR
(95% CI)
Adjusted HR
(95% CI)
Low myopia
Unadjusted 1.00 2.70 (2.22, 3.28)*** 1.45 (1.32, 1.58)***
Main model 1.00 2.73 (2.24, 3.32)*** 1.66 (1.51, 1.82)***
Subgroup effects
Age, years
 0–39 1.00 4.11 (2.96, 5.71)*** 1.81 (1.33, 2.47)***
 40–59 1.00 1.88 (1.41, 2.50)*** 1.72 (1.55, 1.91)***
 ≥ 60 1.00 0.71 (0.18, 2.92) 0.85 (0.56, 1.29)
Sex
 Female 1.00 2.95 (2.21, 3.93)*** 1.44 (1.24, 1.67)***
 Male 1.00 2.55 (1.94, 3.35)*** 1.83 (1.62, 2.07)***
Cataract
 Without 1.00 3.07 (2.49, 3.78)*** 1.82 (1.65, 2.01)***
 With 1.00 1.12 (0.63, 2.00) 0.71 (0.53, 0.95)*
High myopia
Unadjusted 1.00 0.87 (0.39, 1.97) 1.04 (0.81, 1.33)
Main model 1.00 0.83 (0.37, 1.88) 1.05 (0.81, 1.37)
Subgroup effects
Age, years
 0–39 1.00
 40–59 1.00 0.94 (0.38, 2.29) 1.01 (0.75, 1.36)
 ≥ 60 1.00 0.90 (0.12, 6.71) 1.02 (0.51, 2.04)
Sex
 Female 1.00 0.93 (0.29, 2.97) 1.10 (0.75, 1.61)
 Male 1.00 0.75 (0.24, 2.38) 1.02 (0.71, 1.47)
Cataract
 Without 1.00 1.10 (0.41, 3.00) 1.31 (0.97, 1.78)
 With 1.00 0.42 (0.10, 1.78) 0.57 (0.35, 0.94)*
Low/high myopia/astigmatism
 Un-adjust 1.00 2.47 (2.06, 2.97)*** 1.45 (1.33, 1.57)***
 Main model 1.00 2.49 (2.06, 3.00)*** 1.60 (1.47, 1.75)***
Subgroup effects
Age, years
 0–39 1.00 3.94 (2.85, 5.44)*** 1.84 (1.36, 2.48)***
 40–59 1.00 1.80 (1.38, 2.35)*** 1.67 (1.52, 1.83)***
 ≥ 60 1.00 0.85 (0.31, 2.30) 1.02 (0.75, 1.38)
Sex
 Female 1.00 2.69 (2.05, 3.53)*** 1.42 (1.24, 1.62)***
 Male 1.00 2.33 (1.80, 3.03)*** 1.76 (1.57, 1.97)***
Cataract
 Without 1.00 2.94 (2.41, 3.60)*** 1.79 (1.63, 1.96)***
 With 1.00 0.92 (0.54, 1.56) 0.76 (0.60, 0.97)*

CI confidence interval, HR hazard ratio.

* < 0.5, *** < 0.001.

The main model is adjusted for age, sex, CCI, HF, AMI, stroke, ischemic heart disease, angina, peripheral vascular disease, hypertension, hyperlipidemia, renal failure, chronic liver disease, COPD, cataract, level of urbanization, monthly income, and residence.